Ubique Biotech

#HIV early detection is essential—it not only enables timely treatment and improved health outcomes but also significantly reduces transmission rates and encourages preventive measures. The United Nations' 95-95-95 initiative is an ambitious goal to ensure that by 2025, 95% of people living with HIV know their status. At Ubique Biotech we are proud to contribute to this mission with our advanced HIV diagnostic solutions, including state-of-the-art immunoassay affordable reagents using synthetic peptides, designed for early detection and prevention. Whether you're working on high-throughput lab assays or developing user-friendly at-home tests, our dependable reagents equip assay developers with the tools they need to make a lasting impact in the global fight against HIV. Connect with us to explore how our solutions can help you in this crucial work. We support test developers. UNAIDS, World Health Organization, Centers for Disease Control and Prevention, EGPAF EGPAF, Clinton Health Access Initiative, Inc., The Global Fund, Bill & Melinda Gates Foundation, Cepheid #diagnostics #HIVawareness #GlobalHealth #UbiqueBio

Great article from Marta Fernández Suárez (FIND). Strengthening the production of diagnostics in Brazil is crucial for public health and technological autonomy. Local production ensures rapid responses to health emergencies, reduces costs, drives innovation, and creates jobs. At Ubique Biotech, we are developing and licensing hiv, hepatitis and dengue diagnostic reagents for PoC screening and rapid tests. Talk to us if you would like to learn more! #diagnostics #ubiquebio

We’re thrilled to see initiatives like the Global Pandemic Preparedness Summit, co-hosted by Ministério da Saúde, Fundação Oswaldo Cruz (Fiocruz), and CEPI (Coalition for Epidemic Preparedness Innovations), taking place in Rio de Janeiro on July 29-30. This summit aligns perfectly with our mission at Ubique Biotech, as it presents a fantastic opportunity to reignite our efforts in pandemic preparedness and strengthen global defenses against future threats. We are committed to advancing diagnostics and supporting global health initiatives, and we look forward to the collaborative strides that will be made at this important event.

✨ Celebrating #SelfCareDay! At Ubique Biotech, we believe self-care is more than a personal commitment—it’s a crucial driver of health and well-being for individuals, families, and communities. By emphasizing self-care, we empower people to take charge of their #health with confidence and informed decision-making. Our commitment extends beyond self-care. We are at the forefront of advancements in point-of-care diagnostics for #HIV, #Hepatitis, and #Dengue, enhancing the timeliness and accuracy of detection. Our mission is to provide accessible, reliable, and rapid testing solutions to improve health outcomes in affected regions. #HealthInnovation #DengueDiagnostics #PointOfCare #SelfCare #UbiqueBio

The Global Fund has approved over $1.8 million in emergency funding to provide crucial #HIV and #TB prevention services amidst the violence in #Haiti. This initiative targets victims of gender-based violence, displaced people, and other vulnerable groups. At Ubique Biotech, we're committed to supporting such vital efforts with our advanced #diagnostic rapid test solutions. By developing affordable screening solutions using synthetic peptides as reagents we can make a significant impact. To learn more about our innovative solutions, contact us today. Pan American Health Organization | UNAIDS | United Nations Population Fund (UNFPA) #GlobalHealth #HIVPrevention #TBPrevention #SupportHaiti #HealthcareInnovation #BiotechForGood #UbiqueBio

We are thrilled and honored to announce that Ubique Biotech has been recognized among the leading biotech startups in LATAM! 🌟 At Ubique Biotech, our mission is to revolutionize the field of #diagnostics, bringing innovative solutions to improve healthcare outcomes. A special thank you to FrissOn capital, Ian Omar MORALES BURGOS and Pedro LOPEZ SELA for their unwavering support and belief in our vision. Together, we are pushing the boundaries of what's possible in diagnostics. Here's to continued #innovation and success! 🚀 #UbiqueBio #HealthcareInnovation #LATAM #Diagnostics #FrissonCapital #Gratitude #Innovation #Healthcare

🌟 Exciting Opportunity from the World Health Organization! 🌟 The WHO invites manufacturers of #diagnostic products for #dengue to submit an Expression of Interest for product evaluation by the WHO Expert Review Panel for Diagnostic Products. This initiative is crucial for enhancing diagnostics in the fight against dengue. At Ubique Biotech, we are dedicated to pioneering innovative diagnostic solutions. This call aligns perfectly with our mission to develop high-quality, reliable tools for rapid and accurate disease diagnosis. We encourage all stakeholders in the diagnostic industry to participate and contribute to this vital cause. Deadline for submission: 7 July 2024. #GlobalHealth #Diagnostics #Biotech #Innovation #Dengue #WHO #HealthTech #UbiqueBio

🌍🦟 As global temperatures rise, so does the incidence of #dengue fever. According to the World Health Organization, cases have increased 30-fold over the past 50 years, with over 100 countries now at risk. #ClimateChange is expanding the habitat of Aedes mosquitoes, the primary carriers of dengue, making rapid and accurate #diagnostics more critical than ever. #EarlyDetection can save lives and curb outbreaks. Current diagnostic methods can be slow and resource-intensive, which is why we at Ubique Biotech are committed to developing #PoC rapid tests solutions. Rapid diagnostics allow for timely treatment, efficient resource allocation, and better disease management. Developing innovative diagnostic tools is not just a medical necessity but a global imperative to combat the evolving challenges posed by climate change. 🔗 Learn more about dengue and its link to climate change from the WHO: World Health Organization: https://lnkd.in/fhV58XH #Dengue #PublicHealth #WHO #UbiqueBio #Diagnostics

Today we conmemorate #MalariaDay2024. It's imperative we acknowledge the intricate dance between #ClimateChange and #disease. Our planet's shifting climate isn't just altering landscapes; it's also reshaping the very fabric of illnesses like #malaria. Consider the impact of changing #temperatures and #extremeWeather events. These aren't just environmental shifts; they're potential catalysts for the rapid spread of malaria. Floods, in particular, create ideal breeding grounds for mosquitoes, facilitating the transmission of this deadly disease. Yet, in the face of these challenges, at Ubique Biotech #diagnostic remain our essential compass. Many diseases exacerbated by climate change lack the necessary tools for accurate diagnosis, leaving communities vulnerable to outbreaks. As we strive for malaria elimination, it's crucial to prioritize the development and accessibility of diagnostics capable of navigating these climate-induced changes. From pioneering genomic sequencing to innovative wastewater surveillance, cutting-edge diagnostic technologies serve as our frontline defense, anticipating emerging threats and safeguarding the most vulnerable among us. Let's unite our efforts, channeling our collective resolve to combat malaria and climate-driven diseases with affordable diagnostics. #malariaday2024 #diagnostics #ubiquebio

Following our Ubique Biotech "What We Do" series, we're thrilled to share a video featuring our CSO, Angelita Lorenzo, visiting Cytiva in Dasel, #Germany. This comes after we emerged as winners of the Cytiva Immunoassay DX Challenge! We had the opportunity to collaborate with their amazing team to further develop our rapid test and POCT prototypes. Why this matters: Accurate and affordable diagnostics are crucial for everyone, everywhere. This win provides a transformative opportunity to improve global healthcare access. Call to Action: - Watch the video to learn more about our winning solution! - Let us know in the comments what challenges you face in diagnostics. Use case link: https://lnkd.in/dRhScP73 #ubique #healthcare #diagnostics #innovation #CytivaDXChallenge